BRAF and medulloblastoma: This precluded training classifiers for molecular alterations (such as BRAF for pilocytic astrocytomas or the medulloblastoma subgroups [22]), which, of course, is an attractive future research direction given the importance of these markers for diagnosis and also, in part, therapeutic stratification.